Tacromus 0.25 Capsule
By Tacromus
Rx
10 Capsule in a Strip

Composition
Tacrolimus(0.25mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
December, 2026
About Tacromus 0.25 Capsule
Tacromus 0.25 Capsule, also known as Tacrolimus 0.25 mg Capsule 10's, is classified as an immunosuppressant medication. This drug is commonly prescribed in combination with other medications to aid in preventing the rejection of newly transplanted organs like the liver, kidney, or heart. Organ rejection can occur when the body's immune system identifies the transplanted organ as a foreign entity and attempts to remove it. Tacromus 0.25 Capsule contains Tacrolimus, which functions by inhibiting the activity of T and B lymphocytes, key components of the immune system that usually defend the body against foreign substances and infections.
Patients are advised to adhere closely to their doctor's instructions regarding the dosage and frequency of Tacromus 0.25 Capsule intake. The specific amount of the medication and how frequently it should be taken depend on factors such as the type of organ transplant, the patient's body weight, and concurrent medications being consumed. To optimize its effectiveness, Tacromus 0.25 Capsule should be taken on an empty stomach, either at least one hour before or two hours after a meal. It is crucial to maintain a regular intake schedule, even if the patient is feeling well, as stopping the medication abruptly can increase the risk of organ rejection.
While beneficial in preventing organ rejection, Tacromus 0.25 Capsule may also present several potential side effects that require prompt medical attention. Some common adverse effects include the exacerbation of diabetes and kidney issues, tremors, susceptibility to infections, elevated blood pressure, and insomnia. Patients should promptly inform their healthcare provider if these side effects persist or worsen. It is important to note that this medication weakens the immune system, making individuals more susceptible to infections than usual.
Before initiating treatment with Tacromus 0.25 Capsule, patients should inform their doctor about any existing medical conditions such as kidney, liver, or heart problems, diabetes, or high blood pressure. Additionally, it is crucial to disclose all other medications being taken, particularly those for infections, pain, or arthritis, as they may interact with Tacromus 0.25 Capsule. Patients are advised to limit exposure to sunlight and UV light as immunosuppressants can elevate the risk of skin cancer.
Both male and female patients using Tacromus 0.25 Capsule should employ effective birth control methods to prevent pregnancy. The use of this medication during pregnancy or while breastfeeding is generally not recommended unless deemed necessary by a healthcare professional. Regular medical tests and monitoring are essential throughout the treatment to assess progress, with frequent blood pressure checks being a fundamental aspect of the monitoring process.
Benefits
Tacromus 0.25 Capsule, a medication that falls under the category of immunosuppressants, plays a crucial role in preventing organ rejection in transplant patients. Organ rejection occurs when the immune system identifies the new organ as a threat and launches an attack against it. By weakening the immune response, which typically fights infections, this medication significantly reduces the risk of the body rejecting the transplanted organ. Working in conjunction with other medicines, Tacromus 0.25 Capsule enhances the success rate of transplant operations. It contains Tacrolimus, an immunosuppressant that targets the T and B lymphocytes - key players in the immune system's defense mechanism against foreign substances. By suppressing the activity of these cells, which would normally target foreign invaders, Tacromus 0.25 Capsule facilitates the body's acceptance of the new organ and effectively prevents organ rejection in patients who have undergone organ transplants. It is important to adhere to the prescribed dosage and continue taking the medication until advised otherwise by a healthcare professional.
How to use the Tacromus 0.25 Capsule
To use Tacromus 0.25 Capsule, follow your doctor's instructions on the dose and duration. It's important to take this medicine on an empty stomach. If you are taking the capsule form, swallow it whole with water. Do not crush, break, or chew the capsule. If you are taking the granules, mix them with water to create an oral suspension. Drink the suspension immediately and do not store it for later use.
Take Tacromus 0.25 Capsule 1 hour before meals or 2-3 hours after meals, or as directed by your physician. Swallow the capsule with a glass of water and do not crush or chew it. Your doctor will determine the right dose and duration of therapy based on factors like your age, body weight, and medical condition. It's important not to stop taking Tacromus 0.25 Capsule without consulting your doctor first.
Uses of Tacromus 0.25 Capsule
The primary use of Tacromus 0.25 Capsule is for preventing organ rejection in transplant patients. It helps in preventing the rejection of transplanted organs, ensuring the body does not attack the newly transplanted organ. Tacromus 0.25 Capsule is also effective in preventing graft rejection that may occur after an organ transplantation procedure. By taking this medication as prescribed, transplant patients can help maintain the functionality and health of their transplanted organ.
What conditions Tacromus 0.25 Capsule treats?
Organ rejection is a condition where the body's immune system sees a transplanted organ as foreign and reacts to get rid of it. It can happen quickly (hyperacute), within a few months (acute), or after a year or more (chronic). Symptoms differ based on the organ transplanted but include pain, fever, and feeling unwell. If you notice these signs, seek medical help right away.
Should you consult a doctor?
It is important to seek advice from your doctor before taking Tacromus 0.25 Capsule if you have upcoming vaccination schedules. Notify your doctor if you have high blood cholesterol or potassium levels. If you experience any unexpected or severe side effects while taking this medication, consult your doctor immediately for guidance and proper evaluation. Your doctor will be able to provide you with the necessary support and advice to ensure your well-being while taking Tacromus 0.25 Capsule.
Side effects of Tacromus 0.25 Capsule
When taking Tacrograf 0.25 Capsules, some common side effects may occur as your body gets used to the medication. These include increased blood sugar levels, kidney damage, difficulty sleeping, tremors, high blood pressure, and the risk of infections. Other potential side effects to be aware of are nausea, diarrhea, headache, constipation, fever, and further kidney problems. Additionally, some individuals may experience liver problems, feeling shaky, stomach issues, mouth ulcers, changes in blood cholesterol levels, or emotional symptoms like anxiety or depression. Physical effects may include skin rash, muscle pain, weight gain, and changes in vision or hearing sensitivity. It is important to contact your healthcare provider if you notice severe stomach pain, signs of skin or lymph cancer, increased infections, flu-like symptoms, signs of brain infection, kidney damage symptoms, vision changes, allergic reactions, or signs of heart problems while taking this medication.
Safety advice

liver
For individuals with liver disease, caution is advised when using Tacromus 0.25 Capsule. It may be necessary to adjust the dose of the medication. It is important to consult your doctor before taking Tacromus 0.25 Capsule if you have any liver-related issues.

kidney
Tacromus 0.25 Capsule requires caution in patients with kidney disease. Adjusting the dose might be necessary. Always consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Tacromus 0.25 Capsule. Drinking alcohol can have negative effects when combined with this medication.

driving
When taking Tacromus 0.25 Capsule, be cautious while driving. This medication may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if you experience these effects.

pregnancy
Tacromus 0.25 Capsule may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing this medication. Consult your doctor for advice.

breastfeeding
Caution is advised when using Tacromus 0.25 Capsule during breastfeeding. Limited data indicates potential harm to the baby via breastmilk.
Age above 75(Geriatrics)
Age below 6 months(Pediatrics)
Consumption warning before consuming Tacromus 0.25 Capsule
Before consuming Tacromus 0.25 Capsule, it is essential to inform your doctor about any allergies to Tacrolimus or other medications. Pregnant or breastfeeding women should consult a doctor before using this medication. Avoid alcohol while taking Tacromus 0.25 Capsule. Only drive if fully alert, as it may affect vision or cause nervous disturbances in some individuals. Notify your doctor if you are due for a vaccination before starting Tacromus 0.25 Capsule, as it may impact your immune system and increase infection or skin cancer risks. When outdoors, wear protective clothing and sunscreen while using this medication. To prepare the oral suspension, opt for glass or metal materials to avoid the granules sticking to plastic containers, ensuring the full dose for children. Take precaution not to inhale or allow skin or eye contact with the granules or prepared suspension. If accidental contact occurs, wash the area with soap and water or rinse eyes with plain water.
What if you forgot to take Tacromus 0.25 Capsule?
If you forget to take your Tacromus 0.25 Capsule, try to take it as soon as you remember. But if it's close to the time for your next dose, just skip the missed dose. It's important not to take a double dose to make up for the one you missed. Stick to your usual schedule.
What happens if you take overdose of Tacromus 0.25 Capsule?
In the event that you or someone else takes more than the prescribed amount of Tacrograf 0.25mg Capsule, it is crucial to seek prompt medical attention. Overdose symptoms may manifest as tremors, abnormal kidney function resulting in reduced or absent urine output, elevated blood pressure, leg swelling, and feelings of fatigue. It is important not to delay in contacting your doctor or visiting the nearest hospital if overdose is suspected.
Additional Information
| Habit Forming | No |
| Chemical Class | Macrolide Lactams |
| Therapeutic Class | - |
| Action Class | Immunosuppressant- Calcineurin inhibitors |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹96.08
₹113.03
15% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024
